Northwestern Medicine scientists have identified a key driver of chemotherapy resistance in advanced ovarian cancer, ...

Patients with stage IV ovarian cancer can derive long-term benefits from neoadjuvant pembrolizumab and chemotherapy if they achieve a major pathologic response, according to research published in ...

THE NHS has rolled out a new ‘super jab’ that treats 15 different types of cancer – and takes just five minutes. Thousands of ...

INX-315 is an oral, investigational selective cyclin-dependent kinase 2 (CDK2) inhibitor. The designation was based on preclinical data as well as interim data from the ongoing phase 1/2 INX-315-01 ...

Natural killer cells aren't just mindless defenders — a special type, adaptive NK cells, remember their enemies and come back ...

The O'Hern sisters helped each other fight breast cancer. Now they're walking in the 2025 Kentucky Oaks Survivors Parade at ...

A Nashua woman who is battling cancer surprised her 85-year-old mother with the news that she completed her master's degree.

Ovarian cancer is a cancer in the ovary that is located on both sides of the uterus to produce follicles and make female ...

Researchers at Karolinska Institutet have uncovered a unique ability of a special subtype of natural killer cells in the ...

INX-315, a CDK2 inhibitor, gained FDA fast track status in CCNE1-positive platinum-resistant/refractory ovarian cancer.

The selective CDK2 inhibitor INX-315 has been given FDA fast track designation for use in CCNE1-amplified, platinum-resistant ...

That said, if treatment is necessary ... Oral contraceptives can also help reduce your risk of ovarian cancer. The risk of ovarian cancer is higher in postmenopausal females.